AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Potential of Checkpoint Inhibitors in AML and MDS
The speakers discuss the current limitations of checkpoint inhibitors in treating AML and MDS and highlight the potential of targeting the innate immune system for better outcomes. Ongoing studies and clinical trials in this area are also discussed.